Stemina’s Human Cell-Based devTOX quickPredictTM Assay Able to Predict Developmental Toxicity Potential of Nicotine-Containing Products

Stemina’s Human Stem Cell-Based Test Has Potential to Predict Which Drugs and Chemicals Cause Birth Defects

Stemina Launches Cardiotoxicity Assay, Presents Sponsored Session, Poster at SOT’s Annual Meeting and ToxExpo 2018

Stemina Biomarker Discovery Prepares to Commercialize Autism Diagnostic Products; Appoints New Board Member, Heiner Dreismann, PhD, Former Head of Roche Molecular Diagnostics